---

Chairman, President, and CEO, Soligenix

Christopher J. Schaber has over 30 years of experience in the pharmaceutical and biotechnology industry. He also serves on the board of directors of the Biotechnology Council of New Jersey  and the Alliance for Biosecurity. He has been a member of the corporate councils of both the National Organization for Rare Diseases and the American Society for Blood and Marrow Transplantation. Schaber received his BA from Western Maryland College, his MS in Pharmaceutics from Temple University School of Pharmacy, and his PhD in Pharmaceutical Sciences from the Union Graduate School.